While IT remains a trading pick, I am cautious due to potential downside risks in the US market affecting IT jobs. Pharma and FMCG are top picks due to the expected resurgence in consumption, likely to drive strong performances over the next quarters.
RBL Bank shares plunge 8% despite 170% jump in Q2 profit. Should you buy, sell or hold?
RBL Bank shares fell up to 8% despite a 170% year-on-year jump in Q2 FY27 net profit to Rs 481.7 crore. Strong net interest income